MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-10-31, ZEOX had -$436K decrease in cash & cash equivalents over the period. -$741K in free cash flow.

Cash Flow Overview

Change in Cash
-$436K
Free Cash flow
-$741K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-10-31
Net loss
-5,521
Depreciation and amortization expense
73
Amortization of debt discount promissory notes
39
Bad debt expense
0
Change in obligation to repurchase shares
2
Inducement expense to convert notes
136
Stock-based compensation
4,693
Accounts receivable, net of allowance for bad debts
-159
Other receivable
-3
Prepaid expenses
25
Inventories
191
Accounts payable and accrued expenses
200
Deferred revenue
-286
Net cash used in operating activities
-718
Purchase of fixed assets
23
Net cash used in investing activities
-23
Proceeds from exercise of warrants
50
Payments on finance leases
45
Proceeds from sale of common stock
300
Net cash provided by financing activities
305
Decrease in cash
-436
Cash and cash equivalents at beginning of period
657
Cash and cash equivalents at end of period
221
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Zeo ScientifiX, Inc. (ZEOX)

Zeo ScientifiX, Inc. (ZEOX)